Journal of Cardiac Failure
Volume 16, Issue 9 , Pages 728-733 , September 2010

Washout Rate of Cardiac Iodine-123 Metaiodobenzylguanidine is High in Chronic Heart Failure Patients With Central Sleep Apnea

  • Akira Tamura, MD

      Affiliations

    • Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan
    • Corresponding Author InformationReprint requests: Akira Tamura, MD, Internal Medicine 2, Faculty of Medicine, Oita University, Idaigaoka 1-1, Hasama-machi, Yufu 879-5593, Japan. Tel: +81-(0)97-586-5804; Fax: +81-(0)97-549-4245.
    • ,
  • Shinichi Ando, MD, PhD

      Affiliations

    • Division of Cardiovascular Medicine, Saiseikai Futsukaichi Hospital, Fukuoka, Japan
    • ,
  • Yukie Goto, MD

      Affiliations

    • Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan
    • ,
  • Yoshiyuki Kawano, MD

      Affiliations

    • Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan
    • ,
  • Kazuhiro Shinozaki, MD

      Affiliations

    • Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan
    • ,
  • Munenori Kotoku, MD

      Affiliations

    • Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan
    • ,
  • Junichi Kadota, MD, PhD

      Affiliations

    • Internal Medicine 2, Faculty of Medicine, Oita University, Yufu, Japan

Received 1 December 2009 ,Revised 15 April 2010 ,Accepted 29 April 2010.

References 

  1. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–823
  2. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257–1263
  3. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2001;22:1136–1143
  4. Javaheri S, Parker TJ, Wexler L, Michaels SE, Stanberry E, Nishyama H, et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med. 1995;122:487–492
  5. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154–2159
  6. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999;160:1101–1106
  7. Ferrier K, Campbell A, Yee B, Richards M, O'Meeghan T, Weatherall M, et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest. 2005;128:2116–2122
  8. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol. 2006;106:21–28
  9. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625–1631
  10. Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Töpfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail. 2007;9:251–257
  11. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med. 1996;153:272–276
  12. Wilcox I, McNamara SG, Wessendorf T, Willson GN, Piper AJ, Sullivan CE. Prognosis and sleep disordered breathing in heart failure. Thorax. 1998;53(Suppl 3):S33–S36
  13. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999;99:435–440
  14. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61–66
  15. Corrà U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, et al. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation. 2006;113:44–50
  16. Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol. 2007;49:2028–2034
  17. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473–479
  18. Solin P, Kaye DM, Little PJ, Bergin P, Richardson M, Naughton MT. Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest. 2003;123:1119–1126
  19. Spaak J, Egri ZJ, Kubo T, Yu E, Ando S, Kaneko Y, et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension. 2005;46:1327–1332
  20. Mansfield D, Kaye DM, La Rocca BH, Solin P, Esler MD, Naughton MT. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation. 2003;107:1396–1400
  21. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol. 2002;9:75–94
  22. Meguro K, Toyama T, Adachi H, Ohshima S, Taniguchi K, Nagai R. Assessment of central chemosensitivity and cardiac sympathetic nerve activity using I-123 MIBG imaging in central sleep apnea syndrome in patients with dilated cardiomyopathy. Ann Nucl Med. 2007;21:73–78
  23. Nanjo S, Yamashiro Y, Fujimoto S, Yamashina S, Nakanishi R, Fukunaga S, et al. Evaluation of sympathetic activity by 123I-mataiodobenzylguanidine myocardial scintigraphy in dilated cardiomyopathy patients with sleep breathing disorder. Circ J. 2009;73:686–690
  24. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, Tow DE. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. Circulation. 1979;60:760–766
  25. Solin P, Roebuck T, Johns DP, Walters EH, Naughton MT. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med. 2000;162:2194–2200
  26. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999;341:949–954
  27. Javaheri S, Dempsey JA. Mechanisms of sleep apnea and periodic breathing in systolic heart failure. Sleep Med Clin. 2007;2:623–630
  28. Yamada K, Asanoi H, Ueno H, et al. Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure. Am Heart J. 2004;148:964–970
  29. Takahashi T, Shinozaki T, Sugimura K, Ogawa H, Okabe S, Watanabe J, et al. Impact of beta-stimulation to central chemoreceptor sensitivity [abstract]. Circ J. 2004;68(Suppl I):138
  30. Tamura A, Kawano Y, Naono S, Kotoku M, Kadota J. Relationship between beta-blocker treatment and the severity of central sleep apnea in chronic heart failure. Chest. 2007;131:130–135
  31. Tamura A, Kawano Y, Kadota J. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Cir J. 2009;73:295–298
  32. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D, et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation. 1997;96:2586–2594
  33. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995;26:1594–1599
  34. Churchill ED, Cope O. The rapid shallow breathing resulting from pulmonary congestion and edema. J Exp Med. 1929;49:531–537
  35. Paintal AS. Mechanism of stimulation of type J pulmonary receptors. J Physiol. 1969;203:511–532
  36. Reberts AM, Bhattacharya J, Schultz HD, et al. Stimulation of pulmonary vagal afferent C-fibers by lung edema in dogs. Circ Res. 1986;58:512–522
  37. Solin P, Bergin P, Richardson M, et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation. 1999;99:1574–1579
  38. Chenuel BJ, Smith CA, Skatrud JB, Henderson KS, Dempsey JA. Increased propensity for apnea in response to acute elevations in left atrial pressure during sleep in the dog. J Appl Physiol. 2006;101:76–83
  39. Hall MJ, Xie A, Rutherford R, et al. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med. 1996;154:376–381
  40. Mortara A, Sleight P, Pinna GD, et al. Association between hemodynamic impairment and Cheyne-Stokes respiration and periodic breathing in chronic stable congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;84:900–904
  41. Van de Borne P, Oren R, Abouassaly C, Anderson E, Somers VK. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;81:432–436
  42. Bradley TD, Floras JS. Sleep apnea and heart failure: Part II: central sleep apnea. Circulation. 2003;107:1822–1826
  43. Otsuka N, Ohi M, Chin K, Kita H, Noguchi T, Hata T, et al. Assessment of cardiac sympathetic function with iodine-123-MIBG imaging in obstructive sleep apnea syndrome. J Nucl Med. 1997;38:567–572
  44. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147–1159
  45. Iber C, Ancoli-Israel S, Chesson Jr. AL, Quan SF, for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Westchester (Illinois): American Academy of Sleep Medicine 2007.

 See page 732 for disclosure information.

PII: S1071-9164(10)00204-6

doi: 10.1016/j.cardfail.2010.04.012

Journal of Cardiac Failure
Volume 16, Issue 9 , Pages 728-733 , September 2010

Article Tools

* Image Usage & Resolution